as normal. The increased by 6.9 percent in this quarter was due to the three month period in the previous year being lower than usual when a subsidiary reverse a bad debt of 1 million baht in that
the total amount of THB 3,517.29 million. 4.1.3 Financial lease receivables from related party decreased in the amount of THB 1,021.43 million. 4.1.4 Property, plant and equipment decreased in the
of net proceed from base offering in July and over-allotment proceed in August. This proceed would allow us to enhance our capital structure reflecting in net-interest- bearing debt to equity ratio as
2017 to Baht 1,842 million in 2018, primarily due to commercial operation of new plants and an improvement on financing cost mainly attributable to debt refinancing after issuing project bond in May 2018
investing and the cash flow from financing, an increase in inventory of THB 80 million to support the business plan offsetting a decrease in property, plants and equipment of THB 135 million since all the
www.interpharma.co.th 6. Approve to present to the Shareholders' Meeting to consider and approve the issuance of debentures in the amount not exceeding 300 million Baht. The total debt burden of the Company at any one
3,233.5 mm from THB 45,085.6 mm as of 31 December 2017. Besides, if considering the interest-bearing debt, it amounted THB 38,038.9 mm, increased by THB 3,604.4 mm from THB 34,398.5 mm. The main reasons are
interest-bearing debt, it amounted THB 38,038.9 mm, increased by THB 3,604.4 mm from THB 34,398.5 mm. The main reasons are as follows: 1. Decrease in short-term loans from financial institutions of THB 178.2
-term investment) 3.82 0.20% 3.46 0.16% Property, plant and equipment 577.77 30.47% 581.77 27.46% Intangible assets 2.28 0.12% 1.74 0.08% Deferred tax assets 18.94 1.00% 16.90 0.80% Other non-current
% 11.63 0.55% Non-Current Financial Assets (Long-term investment) 3.66 0.19% 3.46 0.16% Property, plant and equipment 565.85 28.84% 581.77 27.46% Intangible assets 3.48 0.18% 1.74 0.08% Deferred tax assets